Where does BioLamina AB rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), BioLamina AB ranks #15,148 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does BioLamina AB hold?

BioLamina AB holds 19 US utility patents granted between 2015 and 2025, spanning 8 technology areas.

What is BioLamina AB's Innovation Score?

BioLamina AB has an Innovation Score of 31.7 out of 100 (39th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is BioLamina AB's patent grant rate increasing or decreasing?

BioLamina AB's recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for BioLamina AB's patents?

BioLamina AB's patents average 14.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the BioLamina AB patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

BioLamina AB

Q: What technology areas does BioLamina AB focus on?

BioLamina AB's top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 17 patents, ranking #632 of 4,144 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

USPTO PatentsView assignee record - 19 granted patents across 8 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Biolamina ranks #15,148 of 49,997 tracked US assignees by granted-patent volume, with 19 patents across 8 technology areas.

#15,148
of 49,997 US assignees by volume: 39th percentile
by Innovation Score (31.7/100): 14.2
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R15148 · Foreign Corporation #15,148 · 19 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-MICRO 19 grants
MID-PACK #15,148/49,997
PHOTO-FINISH Best Accessory Group
CPC-NARROW C12N · 8 areas
INNOV-THIN 31.7/100
CLAIMS-RICH 14.2 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Best Accessory Group LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Biolamina’s 31.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.3 pts (32%) Velocity 2.9 pts (9%) Breadth 10.0 pts (32%) Claim depth 8.5 pts (27%)

Qualcomm Incorporated · highest

85
BioLamina AB · this assignee

32
3D Lighting… · lowest

7

What this shows Biolamina's Innovation Score is 31.7/100 (39th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Biolamina?

Each dot is one of Biolamina’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Biolamina’s own 14.2 claims/patent is ABOVE the 11.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Biolamina vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Biolamina's grants concentrate

BioLamina AB is a focused PatentsView assignee: 8 CPC subclasses with 89.5% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2017 (3 grants) versus a trough of 1 in 2015. By volume, Biolamina sits between Best Accessory Group LLC and Black Sesame International Holding Limited.

Biolamina's three-year grant acceleration

BioLamina AB shows 3 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Best Accessory Gr…

19
Best Pacific Text…

19
Betta Pharmaceuti…

19
Betterup

19
Biological Illumi…

19
Biomet UK Healthc…

19
Biomet UK

19
Black Sesame Inte…

19
Biolamina AB ◀

19

What this shows BioLamina holds 19 patents at rank #15,154, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near BioLamina

By rank, the assignees closest to #15,154 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in BioLamina's primary technology class.

Biolamina's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 39th percentile higher than 39% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

BioLamina AB patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	5.3%
2016	1	5.3%
2017	3	15.8%
2018	1	5.3%
2019	2	10.5%
2020	2	10.5%
2021	3	15.8%
2022	1	5.3%
2023	2	10.5%
2025partial year	3	15.8%

Which technologies does BioLamina AB patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 17

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 6

C07K - Peptides 4

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 3

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 1

Y10T - Technical Subjects Covered BY Former US Classification 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

BioLamina AB's patent record in context - here's where to go next.

BioLamina AB's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 89.5% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #15,148 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare BioLamina AB against Best Accessory Group LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 31.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.